RESTATED AND AMENDED LICENSE AGREEMENTAnd Amended License Agreement • March 28th, 2022 • Skye Bioscience, Inc. • Pharmaceutical preparations • Mississippi
Contract Type FiledMarch 28th, 2022 Company Industry JurisdictionTHIS RESTATED AND AMENDED LICENSE AGREEMENT ("Agreement") is made as of this May 24, 2019 ("Effective Date") by and between the UNIVERSITY OF MISSISSIPPI, SCHOOL OF PHARMACY, an educational institution with a principal address at University, Mississippi 38677 ("UM"), and EMERALD BIOSCIENCE, INC. f/k/a Nemus Bioscience, Inc., a corporation organized and existing under the laws of Nevada with a principal address at 130 North Marina Drive, Long Beach, CA 90803 ("Licensee").
RESTATED AND AMENDED LICENSE AGREEMENT (BWH #A5288)And Amended License Agreement • December 4th, 2003 • Corgentech Inc • Massachusetts
Contract Type FiledDecember 4th, 2003 Company JurisdictionEffective as of January 1, 1999 ("Effective Date"), The Brigham and Women's Hospital, Inc., a Massachusetts non-profit organization having a business address at 75 Francis Street, Boston, MA 02115 ("BWH") and Corgentech Inc., a Delaware corporation having a primary place of business at Suite 460, 601 Gateway Boulevard, South San Francisco, California 94080, ("LICENSEE"), agree as follows:
RESTATED AND AMENDED LICENSE AGREEMENTAnd Amended License Agreement • October 10th, 2020 • Alberta
Contract Type FiledOctober 10th, 2020 JurisdictionCIELO WASTE SOLUTIONS CORP., a corporation duly incorporated and existing pursuant to the laws of the Province of British Columbia (“Cielo”)
RESTATED AND AMENDED LICENSE AGREEMENT (BWH #A5288)And Amended License Agreement • February 6th, 2004 • Corgentech Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 6th, 2004 Company Industry JurisdictionEffective as of January 1, 1999 ("Effective Date"), The Brigham and Women's Hospital, Inc., a Massachusetts non-profit organization having a business address at 75 Francis Street, Boston, MA 02115 ("BWH") and Corgentech Inc., a Delaware corporation having a primary place of business at Suite 460, 601 Gateway Boulevard, South San Francisco, California 94080, ("LICENSEE"), agree as follows:
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH RESTATED AND AMENDED LICENSE AGREEMENTAnd Amended License Agreement • April 21st, 2011 • Vertical Health Solutions Inc • Wholesale-medical, dental & hospital equipment & supplies • Minnesota
Contract Type FiledApril 21st, 2011 Company Industry JurisdictionThis license agreement (“Agreement”) is by and between Mayo Foundation for Medical Education and Research, a Minnesota charitable corporation, located at 200 First Street SW, Rochester, Minnesota 55905-0001 (“Mayo”), and OnPoint Medical Diagnostics, Inc., a for profit Minnesota corporation located at 221 First Avenue SW, Suite 300, Rochester, MN 55902 (“Company”).
RESTATED AND AMENDED LICENSE AGREEMENTAnd Amended License Agreement • August 13th, 2015 • ChromaDex Corp. • Medicinal chemicals & botanical products • Mississippi
Contract Type FiledAugust 13th, 2015 Company Industry JurisdictionTHIS RESTATED AND AMENDED LICENSE AGREEMENT (this “Agreement”) is made as of this June 3, 2015 (“Effective Date”) by and between the UNIVERSITY OF MISSISSIPPI, an educational institution with a principal address at University, Mississippi 38677 (“UM”) and ChromaDex, Inc., a corporation organized and existing under the laws of California with a principal address 10005 Muirlands Blvd, Suite G, Irvine, California 92618 (“CHROMADEX”) (collectively “the Parties”). This Agreement is intended to supersede and replace the previous agreement between the parties dated March 25, 2010 (“the Original Effective Date”), as previously amended on June 3, 2011, and in September 2012.